1064207-24-4

Upstream product

• 278781-89-8 3-benzyloxy-4-methoxy-β-ethyl-β-nitrostyrene 
• 100-44-7 benzyl chloride 
• 6100-74-9 3-hydroxy-4-methoxyacetophenone 
• 100-39-0 benzyl bromide 
• 1602588-36-2 2-benzyloxy-1-methoxy-4-((E)-2-nitrobut-1-enyl)benzene 
• 6346-05-0 3-benzyloxy-4-methoxybenzaldehyde 
• 1064203-07-1 (+/-)-2-benzyloxy-1-methoxy-4-(2-nitrobutyl)benzene 

Downstream Products

• 1064203-14-0 (+/-)-3-ethyl-6-benzyloxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline 
• 1064205-47-5 (+/-)-6-benzyloxy-2-(2,5-dimethoxybenzyl)-7-methoxy-3-methyl-1,2,3,4-tetrahydroisoquinoline 
• 1064203-17-3 (+/-)-6-benzyloxy-3-ethyl-7-methoxy-2-(3,4,5-trimethoxybenzyl)-tetrahydroisoquinoline 
• 1064203-21-9 (+/-)-3-ethyl-6-hydroxy-7-methoxy-2-(3-methoxybenzyl)-1,2,3,4-tetrahydroisoquinoline 
• 1064205-53-3 (+/-)-2-(2,5-dimethoxybenzyl)-6-hydroxy-7-methoxy-3-methyl-1,2,3,4-tetrahydroisoquinoline 
• 1064203-20-8 (+/-)-3-ethyl-6-hydroxy-7-methoxy-2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline 
• 1064203-23-1 (+/-)-3-ethyl-7-methoxy-2-(3-methoxybenzyl)-6-sulfamoyloxy-1,2,3,4-tetrahydroisoquinoline 
• 1064205-58-8 (+/-)-2-(2,5-dimethoxybenzyl)-7-methoxy-3-methyl-6-sulfamoyloxy-1,2,3,4-tetrahydroisoquinoline 
• 1064203-10-6 (+/-)-N-(1-(3-(benzyloxy)-4-methoxyphenyl)butan-2-yl)acetamide 
• 1064203-25-3 (±)-3-ethyl-7-methoxy-6-sulfamoyloxy-2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline 

Relevant academic research and scientific papers

Isoquinoline Derivatives, Methods of Synthesis and Uses Thereof

Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as amyotrophic lateral sclerosis. These compounds and pharmaceutical compositions are also useful as antivirals and antimicrobial agents.

Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R6, X and Y are as described in the description and in the claims, as well as or pharmaceutically acceptable salts, or enantiomers, or diastereomers thereof. The invention also contains compositions including the compounds and methods of using the compounds.

Synthesis, antitubulin, and antiproliferative sar of c3/c1-substituted tetrahydroisoquinolines

The syntheses and antiproliferative activities of novel substituted tetrahydroisoquinoline derivatives and their sulfamates are discussed. Biasing of conformational populations through substitution on the tetrahydroisoquinoline core at C1 and C3 has a pro